These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2159372

  • 1. Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4.
    Lasky SR, Bell W, Huhn RD, Posner MR, Wiemann M, Calabresi P, Eil C.
    Cancer Res; 1990 May 15; 50(10):3087-94. PubMed ID: 2159372
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a vitamin D3-resistant human chronic myelogenous leukemia cell line.
    Lasky SR, Posner MR, Iwata K, Santos-Moore A, Yen A, Samuel V, Clark J, Maizel AL.
    Blood; 1994 Dec 15; 84(12):4283-94. PubMed ID: 7994044
    [Abstract] [Full Text] [Related]

  • 3. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y, Makishima M, Kanatani Y, Kasukabe T, Honma Y.
    Exp Hematol; 1996 May 15; 24(6):682-9. PubMed ID: 8635523
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of JunD by dihydroxycholecalciferol in human chronic myelogenous leukemia cells.
    Lasky SR, Iwata K, Rosmarin AG, Caprio DG, Maizel AL.
    J Biol Chem; 1995 Aug 25; 270(34):19676-9. PubMed ID: 7649976
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of vitamin D receptors in clonal populations of a chronic myelogenous leukemia cell line.
    Iwata K, Kouttab N, Ogata H, Morgan JW, Maizel AL, Lasky SR.
    Exp Cell Res; 1996 May 25; 225(1):143-50. PubMed ID: 8635507
    [Abstract] [Full Text] [Related]

  • 6. Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.
    Clark JW, Posner MR, Marsella JM, Santos A, Uskokovic M, Eil C, Lasky SR.
    J Cancer Res Clin Oncol; 1992 May 25; 118(3):190-4. PubMed ID: 1372318
    [Abstract] [Full Text] [Related]

  • 7. Hormonal responses to 1,25-dihydroxyvitamin D3 in cultured mouse osteoblast-like cells--modulation by changes in receptor level.
    Chen TL, Li JM, Ye TV, Cone CM, Feldman D.
    J Cell Physiol; 1986 Jan 25; 126(1):21-8. PubMed ID: 3003120
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H.
    Clin Cancer Res; 1998 Jul 25; 4(7):1661-72. PubMed ID: 9676840
    [Abstract] [Full Text] [Related]

  • 9. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)2 D3 -induced myeloid differentiation in acute myeloid leukemia cells.
    Song JH, Park E, Kim MS, Cho KM, Park SH, Lee A, Song J, Kim HJ, Koh JT, Kim TS.
    Int J Cancer; 2017 May 15; 140(10):2364-2374. PubMed ID: 28224619
    [Abstract] [Full Text] [Related]

  • 10. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T, Hino M, Inaba M, Nishizawa Y, Morii H, Otani S.
    Arch Biochem Biophys; 1997 Jul 15; 343(2):181-7. PubMed ID: 9224728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A, Miyazawa K, Ohyashiki K, Tauchi T, Boswell HS, Broxmeyer HE, Toyama K.
    Exp Hematol; 1995 Oct 15; 23(11):1153-9. PubMed ID: 7556524
    [Abstract] [Full Text] [Related]

  • 13. Expression of BCR - ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation.
    Cambier N, Zhang Y, Vairo G, Kosmopoulos K, Metcalf D, Nicola NA, Elefanty AG.
    Oncogene; 1999 Jan 14; 18(2):343-52. PubMed ID: 9927191
    [Abstract] [Full Text] [Related]

  • 14. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
    Zhao X, Feldman D.
    Endocrinology; 1993 Apr 14; 132(4):1808-14. PubMed ID: 8384998
    [Abstract] [Full Text] [Related]

  • 15. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells.
    Bondza-Kibangou P, Millot C, El Khoury V, Millot JM.
    Oncol Rep; 2007 Dec 14; 18(6):1513-9. PubMed ID: 17982638
    [Abstract] [Full Text] [Related]

  • 16. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
    Kaur G, Gazit A, Levitzki A, Stowe E, Cooney DA, Sausville EA.
    Anticancer Drugs; 1994 Apr 14; 5(2):213-22. PubMed ID: 8049505
    [Abstract] [Full Text] [Related]

  • 17. Demonstration of vitamin D receptor expression in a human megakaryoblastic leukemia cell line: regulation of vitamin D receptor mRNA expression and responsiveness by forskolin.
    Song LN.
    J Steroid Biochem Mol Biol; 1996 Mar 14; 57(5-6):265-74. PubMed ID: 8639462
    [Abstract] [Full Text] [Related]

  • 18. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 14; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 19. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
    Hussain AM, Lee HC, Chang CF.
    Eur J Cell Biol; 2000 Oct 14; 79(10):697-706. PubMed ID: 11089918
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.